Biomarkers and Surrogate Endpoints for Normal-Tissue Effects of Radiation Therapy: The Importance of Dose–Volume Effects
Open Access
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 76 (3), S145-S150
- https://doi.org/10.1016/j.ijrobp.2009.08.076
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Surrogate End Points for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis From 39 Randomized Controlled Trials of First-Line ChemotherapyJournal of Clinical Oncology, 2007
- A Genetically Determined Dose–Volume Histogram Predicts for Rectal Bleeding among Patients Treated With Prostate BrachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Erythropoietin: High Profile, High ScrutinyJournal of Clinical Oncology, 2007
- Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathologyNature Reviews Cancer, 2006
- Does transforming growth factor-β1 predict for radiation-induced pneumonitis in patients treated for lung cancer?Cytokine, 2006
- Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate CancerClinical Cancer Research, 2006
- Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitisInternational Journal of Radiation Oncology*Biology*Physics, 2005
- The Relation Between Tumour Lethal Doses and the Radiosensitivity of Tumour CellsThe British Journal of Radiology, 1961